Background: Cutaneous adverse drug reactions (CADRs) range from minor reactions to several life threatening complications.
INTRODUCTION
Drug reactions are the unwanted effects on the body exerted by the drugs, which are not the characteristic of the desired pharmacodynamic effects 1 . Cutaneous adverse drug reactions (CADRs) range from minor reactions to several life threatening complications. They are often under reported because of their resemblance with viral exanthemas, collagen vascular diseases and neoplastic processes. A high index of suspicion is required for the prompt diagnosis so that the culprit drug is withdrawn as early as possible and the treatment initiated early to prevent a grave outcome. The list of drugs causing a particular type of reaction is ever expanding due to the introduction of newer drugs for the treatment of diseases.
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This prospective study was conducted to study the clinical spectrum of cutaneous adverse drug reactions, determine the causative drugs responsible for the reactions and to assess the preventability.
METHODS
It was a prospective descriptive study carried out over a period of four years from June 2011 to June 2015 in the Department of Dermatology of Gandaki Medical College Teaching Hospital, Pokhara, Nepal. All the patients attending the Dermatology Outpatient Department and the patients admitted in the wards with suspected cutaneous adverse drug reactions to systemic drugs were included in the study. Prior approval was obtained from the Institutional review committee. Informed consent was obtained from each patient in our study. Cutaneous adverse drug reactions caused by the use of topical medications were excluded from the study. Data collection was done in a preset proforma that included the demographic details of the patients and a detailed clinical history. A detailed history of drug intake, reaction time, previous history of drug reaction, duration of reaction, type of cutaneous reaction, and improvement after the dechallenge were noted. Relevant investigations were done to rule out any infectious etiology. The reaction was considered as preventable if a previous exposure to the suspected causative drug(s) or another drug of the same family had already caused an adverse skin eruption.
Each case was assessed for its causality by using the WHO definitions and was categorized as 'certain', 'probable', 'possible', 'unlikely', 'conditional/ unclassified' and 'unassessable /unclassifiable' 2 . Only the 'certain' and 'probable' cases were included in the study. Data analysis was done using SPSS software.
RESULTS
According to the census, there were altogether 31,396 patients in the Department of Dermatology in four years period, including the outpatients and inpatients. Among them, 102 patients were diagnosed with cutaneous adverse drug reactions. So, the incidence of cutaneous drug reaction was 0.32%. The mean age of the patient was 32 ±15.7 years. Age of the patients ranged from one to 77 years. Maximum patients belonged to the 21 to 30 years age group (Table 1) . There were 59 (58%) female patients and 43 (42%) male patients. Eight patients (7.8%) had severe type of cutaneous adverse drug reactions and the remaining had milder CADR. The most common group of drugs involved in CADR was antibiotics. Among antibiotics, maximum frequency of drug reaction was seen with β lactam antibiotics, penicillin (36%) and cephalosporin (32%). Amoxycillin was the commonest penicillin and cefixime was the commonest cephalosporin causing CADRs. Overall, cefixime caused most of the CADRs. Other antibiotics were ciprofloxacin, levofloxacin, cotrimoxazole, doxycycline, metronidazole and ornidazole. Non steroidal anti-inflammatory drug (NSAID) was the second most common category of drug involved. Among the NSAIDs, the most of the drug reactions were noted with nimesulide, followed by diclofenac. The third common group of drug involved was anticonvulsant and the commonest anticonvulsant involved was phenytoin. Disease-modifying antirheumatic drugs (DMARDs) contributed to around 4% of CADR (Table 3 ).
The three most common types of drug reactions were exanthematous type (45%), fixed drug eruption (17%) and drug induced photosensitivity (8%). Other types of CADR were urticarial, Stevens-Johnson syndrome (SJS), hair loss, pitytriasis rosea, pruritus, pigmentation, purpura, acute generalized exanthematous pustulosis, acneiform eruptions, urticarial vasculitis, psoriasiform eruption, lichenoid eruption, erythroderma, toxic epidermal necrolysis (TEN) and DRESS syndrome. Among the severe types of drug reactions, maximum cases were of SJS ( Table 2 ). The most common type of drug reactions observed in paediatric age group (<14 years age group) was exanthematous drug reaction followed by fixed drug eruption. Other types noted in the paediatric age group were urticarial drug eruption, pruritus, erythroderma and SJS (Table 4) . . It is very important to diagnose CADR as early as possible to prevent the morbidity and mortality from the reactions. The serious reactions can be fatal at times. We had followed the WHO causality definitions to categorize the CADR, as it is a very simple and widely accepted method.
The mean age of our patient was 32 ±15.7 years, comparable to the finding of a Malaysian study 4 but younger than that was seen in French 5 and Italian studies 6 . A female preponderance was noticed in our study. Males were more commonly involved in several other studies 5, [7] [8] [9] [10] [11] . Majority of our patients were in the age group of 21 to 40 years which is comparable with other studies 7, 12 . Lesser number of CADRs were observed in pediatric age group (<14 years) in our study (10%), which is similar to the findings of Dimri D et al 12 and Gonzalez Martin G et al 13 . But some studies have suggested that CADR is more common in younger children and older adults, due to the dysfunctional immune system and inability to metabolize the drugs 14 . Old patients are involved in consumption of a large number of medications with increased incidence of drug reactions. Around seven percent of our patients were of more than 60 years of age.
A wide clinical spectrum of cutaneous adverse drug reactions was observed in our study. Altogether we observed 18 different types of cutaneous adverse drug reactions. Exanthematous type was the commonest type of reaction observed in our study which is in accordance to the finding of several other authors 4, 8, 12, [15] [16] [17] . Fixed drug eruption was the second most common drug eruption seen in our study similar to the finding of Patel RM et al Antimicrobials was the commonest drug category of drug involved in CADR observed by several authors 8, 12, 16 . Antibiotic was the most common cause of CADR in our study. This is similar to the finding of other authors 7, 9, 17 . Cefixime was the most common drug incriminated in CADR in our study. Cotrimoxazole was the most common cause of drug eruptions in other studies 9, 18, 19 . In our study, antibiotics were associated with both non serious as well as serious CADR like SJS.
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NSAIDs induced adverse events most frequently in a study of Kacalak-Rzepka A et al 20 . Anticonvulsants were responsible for the majority of CADRs in a study of Botelho LF et al in around 24% of cases 21 . Antibiotics were implicated in the majority of exanthematous drug reactions (69%) in our study. Sharma VK et al observed that anticonvulsant was the commonest group of drugs implicated in exanthematous reaction 8 . In our study, FDE was most frequently caused by NSAIDs. Sulfonamide was the commonest drug group implicated in FDE in the observation of Sharma VK et al 8 .
The overall incidence of CADR in our study was 0.32%. This finding was similar to the finding of a French survey 5 . A higher incidence rate was reported in an Indian Study 7 .
The reported incidence of CADR in Mid-Western Nepal was 1.6%. Serious CADRs were found in around 9% of our cases. It was 24% in Mid-Western Nepal 9 . Tuchinda P et al observed serious CADR in 16.5% patients 17 . A higher incidence of serious CADR has been reported by other authors 5, 7 . We observed that SJS was the most common type of serious CADR, similar to the observation of other authors 9, 22 . Anticonvulsant was the commonest drug group involved in serious CADR in our study. Anticonvulsants were also responsible for the serious CADR in other studies 8, 21 . DRESS syndrome is one of the severe forms of CADR. The drugs incriminated in DRESS syndrome are anticonvulsants, allopurinol, sulphonamides and antibiotics 23 . We had observed one case of DRESS syndrome that was caused by Leflunomide. DRESS syndrome caused by Leflunomide was also reported by Parajuli S et al 24 . Dress syndrome was caused by allopurinol followed by carbamazepine in a study by Chiou CC et al 25 . Antibiotic was the main culprit drug for DRESS syndrome in a study by Skowron F et al 26 . We had observed one case of toxic epidermal necrolysis caused by ursodeoxycholic acid and one case of acute generalized exanthematous pustulosis (AGEP) caused by the diuretic, amiloride.
In our study, six patients (6%) had previous CADR with the drug of similar category, four had recurrent FDE, one had exanthematous drug reaction and one patient got TEN for second time with ursodeoxycholic acid. Hence, drug preventability was noted to be six percent. Drug preventability has been reported in 15% in other study 5 .
CONCLUSIONS
The commonest type of CADR noted was exanthematous type. Antibiotic was the commonest drug group involved in CADR. Six percent of CADR were preventable.
